Cambium Networks (CMBM) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
30 Apr, 2026Executive summary
Revenue for Q2 2025 was $39.4M, down 12.9% year-over-year, with a net loss of $9.1M and operating loss of $6.6M.
Gross margin improved to 40.8% from 32.5% year-over-year, driven by lower excess and obsolescence reserves and supplier commitment expenses.
Enterprise product revenues grew 53.9% year-over-year, offsetting declines in point-to-multi-point and point-to-point categories.
The company continues to face significant liquidity and going concern risks due to ongoing covenant violations and payment defaults on its credit facilities.
Cost reduction initiatives, including workforce reductions and deferred capital expenditures, are ongoing to align costs with revenue.
Financial highlights
Product revenues fell 14.3% year-over-year to $34.6M; subscriptions and services were flat at $4.8M.
Operating expenses decreased 16.2% year-over-year, mainly from lower R&D and sales/marketing costs due to restructuring.
Interest expense rose 67.3% to $2.3M due to higher rates, increased borrowings, and a 2% penalty from covenant defaults.
Cash used in operations for the first half of 2025 was $14.1M; cash balance at June 30, 2025 was $15.8M.
Outlook and guidance
Management expects continued revenue and gross margin pressure from competitive pricing, macroeconomic uncertainty, and supply chain disruptions.
Ongoing manufacturing transition to Thailand may continue to impact production and customer demand into 2026.
The company is seeking additional capital through divestitures or financing and is working with lenders to address covenant breaches.
Latest events from Cambium Networks
- Virtual meeting to vote on directors, auditor, compensation, and reverse share split; board supports all.CMBM
Proxy filing12 May 2026 - Q3 2025 revenue fell 3.7% year-over-year, with a net loss of $8.5 million and ongoing debt defaults.CMBM
Q3 202530 Apr 2026 - 2024 saw a 21.8% revenue drop, major impairments, and severe liquidity and going concern risks.CMBM
Q4 20247 Apr 2026 - Q2 revenue up 9% sequentially, but down 23% year-over-year, with margin and cash flow gains.CMBM
Q2 20242 Feb 2026 - Revenue and margins improved, but debt covenant breaches threaten financial stability.CMBM
Q3 202415 Jan 2026